Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

Caryn Hughes, Graeme Clemens, Matthew J. Baker

Research output: Contribution to journalArticle

7 Citations (Scopus)
54 Downloads (Pure)

Abstract

High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

Original languageEnglish
Pages (from-to)429-430
Number of pages2
JournalTrends in Biotechnology
Volume33
Issue number8
Early online date10 Apr 2015
DOIs
Publication statusPublished - 17 Jul 2015

Keywords

  • cancer
  • infrared
  • spectroscopy
  • high throughput
  • preclinical screening
  • biomarker

Fingerprint Dive into the research topics of 'Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy'. Together they form a unique fingerprint.

Cite this